Federal Circuit Rules That Defendants' Abbreviated New Drug Applications Did Not Infringe Plaintiffs' Drug Patents

On December 7, 2023, the United States Court of Appeals for the Federal Circuit (“CAFC”) issued an opinion affirming the decision of the District…

Related Keywords

United States ,Delaware , ,Lundbeck ,Lupin Pharmaceuticals Inc ,Lupin Ltd ,United States Court ,District Court ,Takeda United Statesa Inc ,Federal Circuit ,Lupin Pharmaceuticals ,New Drug Application ,Hatch Waxman Act ,Abbreviated New Drug Application ,Hatch Waxman Amendments ,Orange Book ,Takeda United Statesa ,Law ,Lawyers ,Legal ,Aw Firms ,Aw Updates ,Egal Updates ,Egal Developments ,Aw Developments ,Egal Newsletters ,Egal Current Awareness ,Deals ,Egal Advisers ,Egal Advisors ,Egal Directory ,Sa ,Ealthcare Amp Life Sciences ,